1-11 of 11
no-observed-effect level
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Study of Midostaurin + Chemotherapy in Pediatric Patients with Untreated, Newly Diagnosed, FLT3 -Mutated Acute Myeloid Leukemia (AML)

Dirk Reinhardt, MD, Christian Michel Zwaan, Albert Hoenekopp, Julie Niolat, Sophie Ifrah, Florence Noel-Baron, Franco Locatelli, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3835.
https://doi.org/10.1182/blood-2019-128043
Published: 2019
Journal Articles

Preliminary Results from an Ongoing Phase 1/2 Study of INCB057643, a Bromodomain and Extraterminal (BET) Protein Inhibitor, in Patients (pts) with Advanced Malignancies

Andres Forero-Torres, MD, Seth Rosen, MD, David C. Smith, MD, Glenn Lesser, MD, Julio Peguero, MD, Shilpa Gupta, MD, Justin M. Watts, MD, Marcus Noel, MD, Razelle Kurzrock, MD, Haeseong Park, MD, Patricia LoRusso, DO, Catherine C. Coombs, MD, Fred Zheng, MD, Julie Switzky, RN, Swamy Yeleswaram, PhD, Gerald Falchook, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4048.
https://doi.org/10.1182/blood.V130.Suppl_1.4048.4048
Published: 2017
Journal Articles

The BET-Bromodomain Inhibitor OTX015 Is Active As a Single Agent and in Combination with Other Targeted Drugs in Preclinical Models of Mantle Cell Lymphoma

Elena Bernasconi, B.Sc., Chiara Tarantelli, Eugenio Gaudio, PhD, Ivo Kwee, Andrea Rinaldi, Luciano Cascione, Anastasios Stathis, MD, Maria Eugenia Riveiro, MD PhD, Emanuele Zucca, MD, Francesco Bertoni
Journal: Blood
Blood (2014) 124 (21): 3113.
https://doi.org/10.1182/blood.V124.21.3113.3113
Published: 2014
Journal Articles

Genetic Factors Predicting The Response To BET Bromodomain Inhibitors In Lymphoma Lead To New Synergistic Combinations

Eugenio Gaudio, PhD, Ivo Kwee, PhD, Andrea Rinaldi, PhD, Michela Boi, PhD, Elena Bernasconi, B.Sc., Monica Testoni, B.Sc., Anastasios Stathis, MD, Patrice Herait, MD, Kay Noel, PhD, Giorgio Inghirami, Emanuele Zucca, MD, Francesco Bertoni, MD
Journal: Blood
Blood (2013) 122 (21): 3070.
https://doi.org/10.1182/blood.V122.21.3070.3070
Published: 2013
Journal Articles

Mcl-1 Dependence Predicts Response To Vorinostat and Gemtuzumab Ozogamicin In Acute Myeloid Leukemia

William E. Pierceall, PhD, Ryan Lena, BS, Bruno C. Medeiros, MD, Elihu H. Estey, MD, Noel Blake, B.S., Michael Elaschoff, Ph.D., Michael Cardone, PhD, Roland B. Walter, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1305.
https://doi.org/10.1182/blood.V122.21.1305.1305
Published: 2013
Journal Articles

ERG Overexpression Is Highly Associated With ERG Gene Amplifications In Patients With Myeloid Malignancies

Simone Weber, Claudia Haferlach, MD, Louisa Noel, Tamara Alpermann, Wolfgang Kern, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD
Journal: Blood
Blood (2013) 122 (21): 3744.
https://doi.org/10.1182/blood.V122.21.3744.3744
Published: 2013
Journal Articles

Circulating Plasma Cells By Routine Complete Blood Count Identify Patients With Similar Outcome As Plasma Cell Leukemia

Rupin A Shah, M.B.B.S, Satyajit Mohite, M.B.B.S., Veerabhadran Baladandayuthapani, Ph.D., Sheeba K. Thomas, M.D., Donna M. Weber, M.D., Michael Wang, MD, Raymond Alexanian, M.D., Muzaffar H Qazilbash, MD, Uday R Popat, MD, Richard E Champlin, MD, Nina Shah, MD, Qaiser Bashir, MD, Simrit Parmar, MD, Yago Nieto, MD, PhD, Sairah Ahmed, MD, Robert Z. Orlowski, M.D., Ph.D., Jatin J. Shah, M.D.
Journal: Blood
Blood (2013) 122 (21): 5356.
https://doi.org/10.1182/blood.V122.21.5356.5356
Published: 2013
Journal Articles

BH3 Profiling As Predictor Of 5-Azacytidine and Decitabine Clinical Responses

Raoul Tibes, MD, PhD, Steven M. Kornblau, MD, William E. Pierceall, PhD, Ryan Lena, BS, Yi Hua Qiu, MD, Michael Cardone, PhD, Leena Chaudhuri, PhD, Veena Fauble, MD, Michael Elashoff, Noel Blake, B.S., Ruben A. Mesa, MD, James M Bogenberger, PhD
Journal: Blood
Blood (2013) 122 (21): 603.
https://doi.org/10.1182/blood.V122.21.603.603
Published: 2013
Journal Articles

The Brd-Inhibitor OTX015 Is Active in Pre-Clinical Models of Mature B-Cell Lymphoid Tumors

Paola Bonetti, PhD, Michela Boi, Maurilio Ponzoni, Maria Grazia Tibiletti, Anastasios Stahis, Giorgio Inghirami, Kay Noel, PhD, Emanuele Zucca, MD, Francesco Bertoni, MD
Journal: Blood
Blood (2012) 120 (21): 1657.
https://doi.org/10.1182/blood.V120.21.1657.1657
Published: 2012
Journal Articles

Stressed Erythropoiesis In Children with Sickle Cell Disease Is An Indicator of Low Fetal Hemoglobin Production and Increased Disease Severity

Emily R. Meier, MD, FAAP, Colleen Byrnes, Maxine Weissman, MT, ASCP, Y. Terry Lee, Pierre Noel, MD, Naomi L.C. Luban, MD, Jeffery L. Miller
Journal: Blood
Blood (2010) 116 (21): 2666.
https://doi.org/10.1182/blood.V116.21.2666.2666
Published: 2010
Journal Articles

A Phase 1 Study of Moxetumomab Pasudotox, An Anti-CD22 Recombinant Immunotoxin, In Relapsed/Refractory Hairy Cell Leukemia (HCL): Updated Results

Robert J. Kreitman, MD, Martin S. Tallman, MD, Steven Coutre, MD, Tadeusz Robak, MD, PhD, Wyndham H. Wilson, MD, PhD, Maryalice Stetler-Stevenson, MD, PhD, Pierre Noel, MD, David J. FitzGerald, PhD, Manuela Buzoianu, PhD, Robert J. Lechleider, MD, Ira Pastan, MD
Journal: Blood
Blood (2010) 116 (21): 2516.
https://doi.org/10.1182/blood.V116.21.2516.2516
Published: 2010